Digital Twin for Accelerating Vaccine Development & Manufacturing

The COVID-19 pandemic unveiled the crucial need for fast methods of creating and producing new vaccines, but GSK was already on the case. In 2019—before the world knew about SARS-CoV-2—GSK teamed up with Atos and Siemens to create a digital twin of vaccine development and manufacturing. This virtual replica, said Sandrine Dessoy, digital innovation lead at GSK, is “a dynamic tool—a simulation of the vaccine process.”...

Read the article here: www.genengnews.com/topics/bioprocessing/digital-twin-for-accelerating-vaccine-development-manufacturing/